verified SJR 0,595 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Elsevier Inc.

workspace_premium Q2 — Oncology lock_open Open Access

Brachytherapy

Brachytherapy is a journal indexed in SJR in Oncology and Radiology, Nuclear Medicine and Imaging with an H index of 60. It has a price of 2970 €. It has an SJR impact factor of 0,595 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,595.

ISSN: 1538-4721

Publisher: Elsevier Inc.

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,595 Q2

H-index 60

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.970 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,595

H-index

Docs (year)

Docs 3y

375

Total refs

2661

Cites 3y

593

Citable 3y

357

Cites/Doc 2y

1.5

Ref/Doc

31.68

Immediate OA

2970 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Chemotherapy and high-dose-rate brachytherapy in the management of advanced cancers of the nasopharynx

What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms

Early-stage endometrial cancer

Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer

Dosimetric characterization of an encapsulated interstitial brachytherapy source of 125I on a tungsten substrate

Dose-effect response in image-guided adaptive brachytherapy for cervical cancer: A systematic review and meta-regression analysis

Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources

Definition of vaginal doses in intrauterine high-dose-rate brachytherapy

Declining use of brachytherapy for the treatment of prostate cancer

Combined intensity-modulated radiation therapy vs. three-dimensional highly conformal radiotherapy after 125I prostate permanent seed brachytherapy: A comparative treatment planning study

Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma

Clinical outcomes from an innovative protocol using serial ultrasound imaging and a single MR image to guide brachytherapy for locally advanced cervix cancer

SHOW MORE ARTICLES

Chronic pelvic pain following prostate brachytherapy: A case report

A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy

Cesium-137 needle brachytherapy boosts after external beam irradiation for locally advanced carcinoma of the tongue and floor of the mouth

Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer?

Brachytherapy improves outcomes in young men (=60 years) with prostate cancer: A SEER analysis

Brachytherapy for pediatric tumors

Biochemical outcome for hormone-nai¬®ve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation

Automated applicator digitization for high-dose-rate cervix brachytherapy using image thresholding and density-based clustering

Assessment of postbrachytherapy sexual function: A comparison of the IIEF-5 and the MSEFS

Accelerated partial breast irradiation

A Spanner‚Ñ¢ in the works; the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy

A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed‚Ñ¢ Model 6733 125I brachytherapy source

FAQs

Brachytherapy has an SJR of 0,595 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2970 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Brachytherapy is 30%.

Brachytherapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Brachytherapy?

What is the APC / publication cost?

What is the acceptance rate?